Neutrophil-to-lymphocyte ratio: an accurate method for diagnosing infection in cirrhosis

References

• Botwin GJ, Morgan TR. Bacterial infections in cirrhosis. Hepatol Int. 2014 Sep;8(Suppl 2):467–474.
   PubMed Web of Science ®Google Scholar
• Dirchwolf M, Ruf AE. Role of systemic inflammation in cirrhosis: from pathogenesis to prognosis. World J Hepatol. 2015 Aug 8;7(16):1974–1981.
   PubMed Web of Science ®Google Scholar
• Borzio M, Salerno F, Piantoni L, et al. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis. 2001 Jan-Feb;33(1):41–48.
   PubMedGoogle Scholar
• Zhao H, Shi Y, Dong H, et al. Community- or healthcare-associated bacterial infections increase long-term mortality in patients with acute decompensation of cirrhosis. Am J Med Sci. 2018 Feb;355(2):132–139.
   PubMed Web of Science ®Google Scholar
• Arvaniti V, D’Amico G, Fede G, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology. 2010 Oct;139(4):1246–56, 1256.e1-5.
   PubMed Web of Science ®Google Scholar
• Foreman MG, Mannino DM, Moss M, et al. Cirrhosis as a risk factor for sepsis and death. analysis of the National hospital discharge survey. Chest. 2003 Sep;124(3):1016–1020.
   PubMed Web of Science ®Google Scholar
• Perdigoto DN, Figueiredo PN, Tome LF. Clarifying the role of C-reactive protein as a bacterial infection predictor in decompensated cirrhosis. Eur J Gastroenterol Hepatol. 2018 Jun;30(6):645–651.
   PubMed Web of Science ®Google Scholar
• Pieri G, Agarwal B, Burroughs AK. C-reactive protein and bacterial infection in cirrhosis. Ann Gastroenterol. 2014;27(2):113–120.
   PubMedGoogle Scholar
• Deutsch M, Manolakopoulos S, Andreadis I, et al. Bacterial infections in patients with liver cirrhosis: clinical characteristics and the role of C-reactive protein. Ann Gastroenterol. 2018 Jan-Feb;31(1):77–83.
   PubMed Web of Science ®Google Scholar
• Thabut D, Massard J, Gangloff A, et al. Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure. Hepatology. 2007 Dec;46(6):1872–1882. .
   PubMed Web of Science ®Google Scholar
• Bhat T, Teli S, Rijal J, et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther. 2013 Jan;11(1):55–59.
   PubMedGoogle Scholar
• Absenger G, Szkandera J, Pichler M, et al. A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients. Br J Cancer. 2013 Jul 23;109(2):395–400.
   PubMed Web of Science ®Google Scholar
• Halazun KJ, Aldoori A, Malik HZ, et al. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol. 2008 Jan;34(1):55–60.
   PubMed Web of Science ®Google Scholar
• Dn R, Ps K, La S, et al. White blood cells as a novel mortality predictor in haemodialysis patients. Nephrol Dial Transplant. 2003 Jun;18(6):1167–1173.
   PubMed Web of Science ®Google Scholar
• Avanzas P, Quiles J, Lopez De Sa E, et al. Neutrophil count and infarct size in patients with acute myocardial infarction. Int J Cardiol. 2004 Oct;97(1):155–156.
   PubMed Web of Science ®Google Scholar
• Oh BS, Jang JW, Kwon JH, et al. Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma. BMC Cancer. 2013 Feb;15(13):78.
   Web of Science ®Google Scholar
• Alkhouri N, Morris-Stiff G, Campbell C, et al. Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease. Liver Int. 2012 Feb;32(2):297–302.
   PubMed Web of Science ®Google Scholar
• Leithead JA, Rajoriya N, Gunson BK, et al. Neutrophil-to-lymphocyte ratio predicts mortality in patients listed for liver transplantation. Liver Int. 2015 Feb;35(2):502–509.
   PubMed Web of Science ®Google Scholar
• Lin L, Yang F, Wang Y, et al. Prognostic nomogram incorporating neutrophil-to-lymphocyte ratio for early mortality in decompensated liver cirrhosis. Int Immunopharmacol. 2018;56:58–64.
   PubMed Web of Science ®Google Scholar
• Fernandez J, Navasa M, Gomez J, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002 Jan;35(1):140–148.
   PubMed Web of Science ®Google Scholar
• Garcia-Tsao G. Bacterial infections in cirrhosis: treatment and prophylaxis. J Hepatol. 2005;42(Suppl(1)):S85–92.
   PubMed Web of Science ®Google Scholar
• Mousa N, Besheer T, Abdel-Razik A, et al. Can combined blood neutrophil to lymphocyte ratio and C reactive protein be used for diagnosis of spontaneous bacterial peritonitis? Br J Biomed Sci. 2017;75(2):71–75.
   Web of Science ®Google Scholar
• Cai YJ, Dong JJ, Dong JZ, et al. Neutrophil-lymphocyte ratio predicts hospital-acquired bacterial infections in decompensated cirrhosis. Clin Chim Acta. 2017;469:201–207.
   PubMed Web of Science ®Google Scholar
• Kwon JH, Jang JW, Kim YW, et al. The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis. BMC Gastroenterol. 2015 Oct;23(15):146.
   Web of Science ®Google Scholar
• Sargenti K, Prytz H, Strand A, et al. Healthcare-associated and nosocomial bacterial infections in cirrhosis: predictors and impact on outcome. Liver Int. 2015 Feb;35(2):391–400.
   PubMed Web of Science ®Google Scholar
• Collaborators GC. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2020 Mar;5(3):245–266.
   PubMed Web of Science ®Google Scholar
• Lázaro-Pacheco IB, Servín-Caamaño AI, Pérez-Hernández JL, et al. Proton pump inhibitors increase the overall risk of developing bacterial infections in patients with cirrhosis. Arq Gastroenterol. 2018.
   Google Scholar